Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS

• DOI: 10.1093/humrep/det114
• Publication Date: 2013-04-27T01:22:47Z
• Authors: G. T. Lainas; E. M. Kolibianakis; I. A. Sfontouris; I. Z. Zorzovilis; G. K. Petsas; T. G. Lainas; B. C. Tarlatzis
• Keywords: Gonadotropin-releasing hormone antagonist; Hormone antagonist

STUDY QUESTIONDo high-risk patients who develop severe early ovarian hyperstimulation syndrome (OHSS) and receive low-dose GnRH antagonist in the luteal phase have lower live birth rates compared with do not OHSS phase?